Literature DB >> 3663343

Treatment of impending carotid rupture with detachable balloon embolization.

M C Zimmerman1, R A Mickel, D J Kessler, C M Mehringer, G B Hieshima, T C Calcaterra.   

Abstract

Acute carotid artery rupture is frequently heralded by prodromal arterial bleeding. This warning signal provides the physician with a brief interval in which to hemodynamically stabilize a patient, electively occlude the carotid, and consequently improve the patient's chance of survival. For three years, we have employed an initial nonoperative approach to patients with impending carotid rupture. A trial of endovascular balloon occlusion followed by detachable balloon embolization of the carotid artery has been utilized. Patients unable to tolerate temporary occlusion underwent a vascular bypass procedure followed by embolization. Six patients have undergone this approach, and all had permanent cessation of bleeding. None died as a result of the procedures. One patient developed permanent neurologic deficits. Balloon embolization offers improved results over elective ligation and should be considered as an alternative treatment for patients in this dire predicament.

Entities:  

Mesh:

Year:  1987        PMID: 3663343     DOI: 10.1001/archotol.1987.01860110035005

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

1.  Internal carotid artery injury during functional endoscopic sinus surgery and its management.

Authors:  Mark Weidenbecher; Walter J Huk; Heinrich Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-01-19       Impact factor: 2.503

2.  Giant mycotic aneurysm of the internal carotid artery in a child: endovascular treatment.

Authors:  Craig B Glaiberman; Richard B Towbin; Danielle K B Boal
Journal:  Pediatr Radiol       Date:  2002-12-19

3.  Preliminary experience with endovascular reconstruction for the management of carotid blowout syndrome.

Authors:  Walter S Lesley; John C Chaloupka; John B Weigele; Sundeep Mangla; Mohammad A Dogar
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.